Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Rusakiewicz

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Current Opinion in Immunology|July 28, 2006
Immunotherapeutic peptide vaccination with leukemia-associated antigensSylvie Rusakiewicz, Jeffrey J Molldrem
Oncoimmunology|October 10, 2015
Natural killer cell mediated immunosurveillance of pediatric neuroblastomaMichaela Semeraro, Sylvie Rusakiewicz, Laurence Zitvogel, et al.
Cancer Immunology, Immunotherapy : CII|April 11, 2009
BCR/ABL-specific CD8+ T cells can be detected from CML patients, but are only expanded from healthy donorsSylvie Rusakiewicz, Alejandro Madrigal, Paul Travers, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Immunotherapy with alloreactive T-cells?Alejandro J Madrigal, Sylvie Rusakiewicz, Anthony I Dodi, et al.
Nature Reviews. Clinical Oncology|April 1, 2016
Immunological off-target effects of imatinibLaurence Zitvogel, Sylvie Rusakiewicz, Bertrand Routy, et al.
Frontiers in Immunology|December 28, 2012
Natural killer cells in non-hematopoietic malignanciesMélanie Desbois, Sylvie Rusakiewicz, Clara Locher, et al.
European Journal of Cancer (Oxford, England : 1990)|December 10, 2015
Rationale for anti-OX40 cancer immunotherapySandrine Aspeslagh, Sophie Postel-Vinay, Sylvie Rusakiewicz, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2009
The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantationMark Tuthill, Frederick Chen, Samantha Paston, et al.
Annals of the New York Academy of Sciences|September 23, 2009
Witch hunt against tumor cells enhanced by dendritic cellsClara Locher, Sylvie Rusakiewicz, Antoine Tesnière, et al.
Cancer Immunology, Immunotherapy : CII|May 6, 2009
Soluble HLA/peptide monomers cross-linked with co-stimulatory antibodies onto a streptavidin core molecule efficiently stimulate antigen-specific T cell responsesSylvie Rusakiewicz, Geraldine Aubert, Richard E Clark, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Current Opinion in Immunology|July 28, 2006
Immunotherapeutic peptide vaccination with leukemia-associated antigensSylvie Rusakiewicz, Jeffrey J Molldrem
Oncoimmunology|October 10, 2015
Natural killer cell mediated immunosurveillance of pediatric neuroblastomaMichaela Semeraro, Sylvie Rusakiewicz, Laurence Zitvogel, et al.
Cancer Immunology, Immunotherapy : CII|April 11, 2009
BCR/ABL-specific CD8+ T cells can be detected from CML patients, but are only expanded from healthy donorsSylvie Rusakiewicz, Alejandro Madrigal, Paul Travers, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Immunotherapy with alloreactive T-cells?Alejandro J Madrigal, Sylvie Rusakiewicz, Anthony I Dodi, et al.
Nature Reviews. Clinical Oncology|April 1, 2016
Immunological off-target effects of imatinibLaurence Zitvogel, Sylvie Rusakiewicz, Bertrand Routy, et al.
Frontiers in Immunology|December 28, 2012
Natural killer cells in non-hematopoietic malignanciesMélanie Desbois, Sylvie Rusakiewicz, Clara Locher, et al.
European Journal of Cancer (Oxford, England : 1990)|December 10, 2015
Rationale for anti-OX40 cancer immunotherapySandrine Aspeslagh, Sophie Postel-Vinay, Sylvie Rusakiewicz, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2009
The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantationMark Tuthill, Frederick Chen, Samantha Paston, et al.
Annals of the New York Academy of Sciences|September 23, 2009
Witch hunt against tumor cells enhanced by dendritic cellsClara Locher, Sylvie Rusakiewicz, Antoine Tesnière, et al.
Cancer Immunology, Immunotherapy : CII|May 6, 2009
Soluble HLA/peptide monomers cross-linked with co-stimulatory antibodies onto a streptavidin core molecule efficiently stimulate antigen-specific T cell responsesSylvie Rusakiewicz, Geraldine Aubert, Richard E Clark, et al.
Pageof 6